NetworkNewsBreaks

FridayAug 20, 2021 10:56 am

NetworkNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Releases H1 2021 Financial and Operational Report, Guidance for H2

Flora Growth (NASDAQ: FLGC), an all-outdoor cultivator and manufacturer of cannabis-derived products and brands, has reported financial and operating results for the six-month period ending June 30, 2021. Highlights of the report include revenue of more than $2 million with an estimated unaudited gross profit of 60% as compared to revenues of  approximately $100,000 for 2020, operating expenses of $6 million, and a cash balance of approximately $19 million with minimal debt. In addition, an operational highlight for the company included the signing of a major distribution deal with a significant Colombian food distributor Flora Growth expects to generate more…

Continue Reading

ThursdayAug 19, 2021 3:53 pm

NetworkNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Strong Q2 2021 Results, Eyes Highly Successful Remainder of 2021

Pressure BioSciences (OTCQB: PBIO) (“PBI”), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and platform technology solutions to the worldwide life sciences and other key industries, today announced continued strong financial results for the second quarter ended June 30, 2021. In addition, the company provided a business update and offered guidance for the remainder of FY 2021. Among the highlights, the company reported a 127% increase in total revenue for Q2 2021 to $608,900 compared to $268,200 for Q2 2020, as well as a 178% increase in instrument sales to $337,400 compared to $121,400 for…

Continue Reading

ThursdayAug 19, 2021 2:48 pm

NetworkNewsBreaks – BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE:7BC) Enters Strategic White-Label Cannabis Beverage Manufacturing Agreement

BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC), an emerging leader in innovative health and wellness beverages and products, today announced its entry into a definitive agreement with the Tinley Beverage Company Inc. (CSE: TNY) (OTCQX: TNYBF) to co-manufacture its award-winning cannabis-infused beverages for the Canadian market. Under the agreement, BevCanna will produce and distribute the full line of Tinley’s ready-to-drink, adult beverage-inspired sparkling Tinley’s Classics, Canadian versions of Tinley’s Tonics, currently available in California. BevCanna will also produce Tinley’s blue agave and lime-inspired Stone Daisy, the juniper berry and lime-inspired Juniper Sky and the blue agave, grapefruit and lime-inspired…

Continue Reading

ThursdayAug 19, 2021 1:15 pm

NetworkNewsBreaks – American Cannabis Partners Eyes Expansion into Additional States

American Cannabis Partners (“ACP”), a sustainable Jamaican experience canna-business innovator, is a company that prides itself on the level of detail given to growing its plants. By leveraging partnerships with Soilscapes and Link4 Systems, the company has created exact soil conditions, growing supplements, water makeup and environments that mimic Orange Hill in Jamaica. “This has resulted in yields well above industry norms and the production of some of the most sought-after flower in the U.S.,” reads a recent article. “Since its beginning in 2018, ACP has acquired 12 cannabis licenses, 20,000 sq. ft of cultivation license in California, and 540,000…

Continue Reading

ThursdayAug 19, 2021 12:54 pm

NetworkNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM), BayMedica Collaborate to Build Leading Rare Cannabinoid Company

InMed Pharmaceuticals (NASDAQ: INM) is a clinical-stage company developing cannabinoid-based pharmaceutical drug candidates and manufacturing technologies for pharmaceutical-grade rare cannabinoids. The company is creating a pipeline of drug candidates to treat various diseases with high unmet medical needs. “In a move to grow its market presence and strengthen its operations, the company announced that it had entered into a non-binding letter of intent (“LOI”) to acquire BayMedica Inc.,” reads a recent article. “This announcement followed the two parties’ reciprocal research collaboration agreement back in November 2020, which saw them collaborate on several projects since. The agreement allowed BayMedica to assess…

Continue Reading

ThursdayAug 19, 2021 12:37 pm

NetworkNewsBreaks – Grapefruit USA Inc. (GPFT) Targeting Q3 2021 Entry into Canada for Innovative Hourglass(TM) Cream

Grapefruit USA (OTCQB: GPFT) recently announced an agreement with 6PAK Solutions Inc., a well-respected Canadian cannabis manufacturer and arm of ATG Pharma Inc. The agreement set the wheels in motion for targeted entry into Canada for its patented Hourglass(TM) Time Release THC+CBD Delivery Topical Relief Cream, one of the most effective cannabis topical creams on the market. A recent article reads, “According to the agreement, GPFT will file a Notice of New Cannabis Product (‘NNCP’) with Health Canada; the NNCP outlines the Hourglass production process including the integration of Grapefruit’s patented Z-Pod Xerogel Silica Gel technology into the Hourglass topical…

Continue Reading

ThursdayAug 19, 2021 12:27 pm

NetworkNewsBreaks – FingerMotion Inc. (FNGR) Achieves Fourth Consecutive Quarter of Record Revenue

FingerMotion (OTCQX: FNGR) recently announced its financial results for the three months ending May 31, 2021 (“Q1 2022”). The company generated a revenue of $6 million, which included contributions from its SMS & MMS, Telecommunications Products & Services, and Big Data Businesses. “The SMS & MMS business recorded a growth in revenue of $1.81 million or 77% compared to Q1 2021; the Telecommunications Products & Services business recorded a revenue growth of $1.34 million or 341% compared to Q1 2021,” reads a recent article. The company also recorded revenues of $98,715 or 198% in quarter-over-quarter growth in its Big Data…

Continue Reading

ThursdayAug 19, 2021 12:16 pm

NetworkNewsBreaks – Sustainable Green Team Ltd.’s (SGTM) Solutions Are Rooted in Sustainability, Vertically Integrated Operations

Sustainable Green Team (OTC: SGTM), a leading provider of environmentally beneficial solutions for tree and storm waste disposal, is focused on lessening the environmental burden caused by tree debris on landfills around the U.S. According to Solid Waste Environmental Excellence Performance (“SWEEP”), the U.S. is on course to run out of landfill space in the next 15 years (https://nnw.fm/5L40t). “Sustainable Green Team’s solutions are rooted in sustainability and based on vertically integrated operations,” reads a recent article. “In the event of a storm, SGTM’s team is deployed from a mobile command center to designated sites to strategize with national partners.…

Continue Reading

ThursdayAug 19, 2021 12:04 pm

NetworkNewsBreaks – Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) Positioning in Growing Point-of-Care Diagnostics and Testing Market

Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF) completed the initial systems testing on HealthTab(TM), its turnkey point-of-care testing solution for pharmacies, demonstrating that it was operating successfully after implementation in the first 11 Shoppers Drug Mart(R) locations where it was launched. “The rollout is a part of the master agreement and statement of work. Under this agreement, the initial Ontario locations receive the point-of-care testing platform from HealthTab(TM) that features the Afinion2(TM) blood chemistry analyzers by Abbott Rapid Diagnostics,” reads a recent article. “The program's initial focus is to screen patients at risk or already diagnosed with diabetes and cardiovascular disease,…

Continue Reading

ThursdayAug 19, 2021 11:51 am

NetworkNewsBreaks – Immunic Inc. (NASDAQ: IMUX) Secures $45M in Underwritten Public Offering

Immunic (NASDAQ: IMUX) has announced the closing of an underwritten public offering of 4,500,000 shares of its common stock at a public offering price of $10.00 per share. According to the update, the company received total proceeds of $45 million from the offering, before deducting underwriting discounts and other expenses. Immunic intends to use net proceeds of the offering to fund the ongoing clinical development of its three lead product candidates, IMU-838, IMU-935 and IMU-856, as well as for other general corporate purposes. Roth Capital Partners acted as co-manager for the offering. To view the full press release, visit https://nnw.fm/mEuDE…

Continue Reading